Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine
Clinical trial NCT02246075 · WITHDRAWN
Trial details
- NCT number
- NCT02246075
- Sponsor
- FORUM Pharmaceuticals Inc
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2016-10-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.